Healthcare with humans in mind

We’ve engineered the Prenuvo experience for speed, accuracy, and safety — with your comfort at the core.

An MRI like no other

Optimized hardware

We work closely with top MRI manufacturers to configure our machines for diagnostic-quality, whole body imaging.

Optimized software

Our software acquisition protocols & calibration provide this multi-parametric diagnostic yield in under one hour.

Future enhancements with AI

We’re actively investigating AI for even better quantification and accuracy, longitudinal tracking over routine scans, and medical research breakthroughs.

We empower our radiologists to give you the very best insights

The human touch

Every Prenuvo report is carefully interpreted and reported by a radiologist. They’ll also provide helpful context in the report for you and your doctor.

Your health as a whole

Our radiologists are specialized in whole body screening, rather than simply focusing on individual organs. This means you get holistic insights that keep your entire health in mind.

Tailored technology

We continually develop our radiology tools specifically for radiologists, making it easier for them to conduct screenings and assess your risks accurately.

Lie back and relax

We’ve designed the scan to significantly reduce anxiety that people might expect from an MRI.

Our machines have a spacious chamber, and you can speak with our technologists at any time during the scan.

You can also listen to auditory beats from HealthTunes or watch your favorite show. Just don’t pick anything with a cliffhanger — you’re all done in under an hour.

What to expect

Your health in
your hands

When your results are ready, you’ll get a comprehensive report in the Prenuvo app. A Prenuvo nurse practitioner will walk you through your results, and call out the things that you may want to bring up with your doctor.

Learn more about reporting

What we scan for

We check for hundreds of conditions*, including most solid tumors at Stage 1, and silent killers like aneurysms. Here are some of the conditions we can catch:

See all conditions

The healthcare system needs to catch up

1 in 2 people will develop some form of cancer in their lifetime.¹

But only 4 types of cancers are generally recommended for regular screening.²

Yet only 14% of diagnosed cancers are detected by those screenings.³

The other 86% are either not caught by screening or don’t have screening tests.⁴

But catching cancers at stage 1 can increase the chance of survival. With Prenuvo, patients can be alerted to conditions before symptoms appear – and when the chance of a cure is highest.

1. Centers for Disease Control and Prevention | 2, 3, 4. NORC at the University of Chicago. (2022). Percent of Cancers Detected by Screening in the U.S. Available at https://cancerdetection.norc.org

Why Prenuvo?
Because we’re voxel visionaries

Voxels are the 3D pixels that our software builds, based on the MRI data we capture. Our expertise on this process is so deep, we’ve literally written the standards on it.

Voxels captured
in 50 minutes

At Prenuvo, we can acquire far more voxels at a diagnostic-quality signal-to-noise ratio compared to the average scan, in a fraction of the time.

Different tissue
weights

Prenuvo scans as much as 5 times more weightings, helping radiologists determine if a lesion is benign or concerning, greatly reducing the rate of false positives.

Number of voxel-averages acquired

Prenuvo scans have unmatched image quality. Our whole body study comprises 181M voxel-averages of DWI imaging, while the average scan can acquire between 1.8–44M

Read white paper

New discoveries every day

We are thrilled to announce that our abstract, titled "AI-Based MR Image Analysis of Female Reproductive System," has been accepted for oral presentation at the Female Pelvis session during the upcoming ISMRM conference on Monday, May 6th, 2024! Our research focuses on leveraging AI to analyze MR images of the female reproductive organs, providing precise insights into uterine zones, ovaries, pelvic fluid, and the establishment of standard aging and menstrual cycle curves. The attached figures reflect findings of a study on normative aging and menstrual cycle trends in large populations of N=9334, and N=3029, respectively. A) uterine; B) ovarian; and C) uterine zonal volume metrics through aging and D) ovarian, E) endometrial volume metrics through menstrual cycle are shown. Regression analysis is conducted in each decade with distributions visualized using boxplots. Our finding for reproductive organs generally aligns with the prior studies and expected trends in these large cohorts.

Physical exercise has been celebrated as a critical element in enhancing one's general well-being; however, its impact on brain health remained largely unexplored until recently.

Fatty liver disease is a common condition caused by the storage of extra fat in the liver. It's been well studied that excessive alcohol consumption can cause liver disease, however non-alcoholic fatty liver disease (NAFLD) is now on the rise, affecting up to 40% of the US population. NAFLD refers to fatty liver disease that is not related to alcohol use. There are two main types: - Non-alcoholic fatty liver disease (NAFLD): when you have excess fat in your liver but no damage to it. - Non-alcoholic steatohepatitis (NASH): when you have exce

In an era where healthcare operates in silos, having comprehensive data about a person’s entire body enables us to unlock remarkable discoveries through correlation. Our AI-assisted research allowed us to complete a study examining the impact of smoking on brain health. While previous research has shed light on this topic, our approach to further investigate the effects of smoking on the brain investigates these effects in participants without existing diagnoses. Our findings, presented at the American Academy of Neurology 2023, offer valuable insights that may help inform preventive measures.

*The Prenuvo whole-body MRI screening:

The Prenuvo whole-body MRI screening: (1) can serve as an adjunct to, but is not intended to replace, other established evidence–based screening practices for early detection of specific malignancies (e.g. colonoscopy, dedicated breast imaging, Pap-smear screening for cervical cancer, low-dose chest CT for high risk patients), (2) may not detect some very small cancers that happen to have an MRI appearance very similar to nearby normal tissue structures. We can generally identify cancerous lesions once they are approximately one centimeter in size, although the size limit of detection varies and may be lower in some parts of the body (e.g. the brain) and higher in other parts (e.g. the chest). Our method may not detect lesions in the lining tissue (mucosa) of various body parts, including the mouth, nose, throat, and gastrointestinal tract. As with any medical test, there are limitations, which make it impossible to detect all malignancies and disease conditions, (3)t does not evaluate the heart or heart vessels, (5) does not evaluate detailed lung microarchitecture or pulmonary micronodules, (6) does not replace dedicated breast imaging for screening or diagnostic evaluation (e.g. mammography, breast ultrasound, breast MRI with contrast), (7) is limited in the evaluation of the gastrointestinal tract and does not replace endoscopy or colonoscopy (e.g. cannot detect gastrointestinal polyps), (8) is limited in its assessment of the large joints as the exam is not tailored for detailed evaluation of the joint ligaments, cartilage, menisci, and labrum, (9) should not be considered a primary screening modality of the skin – this is best assessed by direct physical examination, (10) does not visualize smaller brain vessels – as with any imaging test, there are limitations, and stenosis or certain blood flow abnormalities may not be detected, (11) is not intended to replace dedicated diagnostic imaging in the setting of specific clinical diagnostic questions.